| Full Name | Vaxxim Inc. |
|---|---|
| Speciality | Clinic/center - Community Health |
| Location | 610 Rustic St, Opelika, Alabama |
| Authorized Official Name and Position | Gary A Wood (MANAGER) |
| Authorized Official Contact | 3343193279 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Vaxxim Inc. 610 Rustic St Opelika AL 36801-3434 Ph: (334) 319-3279 | Vaxxim Inc. 610 Rustic St Opelika AL 36801-3434 Ph: (334) 319-3279 |
| NPI Number | 1285841577 |
|---|---|
| Provider Enumeration Date | 05/17/2007 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285841577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QC1500X | Clinic/center - Community Health | 1-066975 (Alabama) | Primary |
News Archive
Even the strongest glues collapse when soaked. Just watch a band-aid slide ungracefully off a finger or toe while in the shower. However, with support from the Office of Naval Research, one researcher has developed a nature-inspired adhesive that stays sticky when wet.
The commercial track record with transcatheter mitral valve repair, approved for patients at high risk for surgery, compares favorably with pre-approval reports, according to findings from a U.S. registry presented at the American College of Cardiology's 64th Annual Scientific Session.
Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.
The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug.
So often the rare informs the common. Penn researchers investigating a regulatory protein involved in a rare genetic disease have shown that it may be related to epileptic and autistic symptoms in other more common neurological disorders.
› Verified 1 days ago
Hndt Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2609 Village Professional Dr, Suite 3, Opelika, AL 36801 Phone: 334-749-6523 Fax: 334-742-0242 | |
East Alabama Medical Development Associates, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-705-1822 Fax: 334-705-1407 | |
Beauregard Family Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7667 Al Highway 51 Ste B, Opelika, AL 36804 Phone: 334-707-7174 | |
Internal Medicine Associates P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 121 N 20th St, #6, Opelika, AL 36801 Phone: 334-749-3385 Fax: 334-745-7672 | |
Aspire Integrative Health Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2202 Gateway Dr Ste D, Opelika, AL 36801 Phone: 334-203-1723 | |
Beauregard Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7667 Alabama Hwy 51 Suite B, Opelika, AL 36804 Phone: 334-737-5557 Fax: 334-767-5646 | |
Employee Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2000 Waverly Pkwy, Opelika, AL 36801 Phone: 334-528-7200 Fax: 334-528-3478 |